XL

Acceleron Pharma

- NASDAQ:XLRN
Last Updated 2024-04-19
  • Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.

  • Locations

    • Cambridge MA

  • Total Funding (USD)

    141.7 million

  • Industries

    Real Estate

  • Security

    Type: ORD
    CUSIP: 00434H108
    ISIN: US00434H1086
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo